CytoReason is a startup based in Israel, most recent round Series-c-plus, 2 tracked investors.
CytoReason is a startup founded in 2016 based in Israel. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
CytoReason develops an AI-powered platform that builds computational disease models to accelerate drug discovery and development for pharmaceutical companies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.